Surface charge of Streptococcus pneumoniae predicts serotype distribution

Infection and Immunity

Volumn 81, Issue 12, 2013, Pages 4519-4524

  Li, Yuan ^a   Weinberger, Daniel M ^a,b   Thompson, Claudette M ^a   Trzciński, Krzysztof ^a,c   Lipsitch, Marc ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b YALE UNIVERSITY   (United States)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BACTERIAL CELL; BACTERIAL STRAIN; BACTERIUM ISOLATE; CELL ENCAPSULATION; CELL SURFACE; CONTROLLED STUDY; ELECTRIC FIELD; ELECTROPHORETIC MOBILITY; GENETIC BACKGROUND; HUMAN; HUMAN CELL; IN VITRO STUDY; NEUTROPHIL; NONHUMAN; PHAGOCYTOSIS; PREVALENCE; PRIORITY JOURNAL; SEROTYPE; STATIC ELECTRICITY; STREPTOCOCCUS PNEUMONIAE; SURFACE CHARGE; ZETA POTENTIAL; BACTERIAL CAPSULE; CELL CULTURE; CLASSIFICATION; IMMUNE EVASION; IMMUNOLOGY; METABOLISM; PNEUMOCOCCAL INFECTION;

PNEUMOCOCCUS VACCINE;

BACTERIAL CAPSULES; CELLS, CULTURED; HUMANS; IMMUNE EVASION; NEUTROPHILS; PHAGOCYTOSIS; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; STATIC ELECTRICITY; STREPTOCOCCUS PNEUMONIAE;

EID: 84891717626     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00724-13     Document Type: Article

References (41)

1. Simell B, Auranen K, Kayhty H, Goldblatt D, Dagan R, O'Brien KL, Pneumococcal Carriage Group. 2012. The fundamental link between pneumococcal carriage and disease. Exp. Rev. Vaccines 11:841-855.
2. Bogaert D, De Groot R, Hermans PW. 2004. Streptococcus pneumoniae colonisation: the key to pneumococcal disease. Lancet Infect. Dis. 4:144-154.
3. HausdorffWP, Feikin DR, Klugman KP. 2005. Epidemiological differences among pneumococcal serotypes. Lancet Infect. Dis. 5:83-93.
4. Babl FE, Pelton SI, Theodore S, Klein JO. 2001. Constancy of distribution of serogroups of invasive pneumococcal isolates among children: experience during 4 decades. Clin. Infect. Dis. 32:1155-1161.
5. HausdorffWP, Bryant J, Paradiso PR, Siber GR. 2000. Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I. Clin. Infect. Dis. 30:100-121.
6. Brueggemann AB, Griffiths DT, Meats E, Peto T, Crook DW, Spratt BG. 2003. Clonal relationships between invasive and carriage Streptococcus pneumoniae and serotype- and clone-specific differences in invasive disease potential. J. Infect. Dis. 187:1424-1432.
7. Brueggemann AB, Peto TE, Crook DW, Butler JC, Kristinsson KG, Spratt BG. 2004. Temporal and geographic stability of the serogroupspecific invasive disease potential of Streptococcus pneumoniae in children. J. Infect. Dis. 190:1203-1211.
8. Hanage WP, Kaijalainen TH, Syrjanen RK, Auranen K, Leinonen M, Makela PH, Spratt BG. 2005. Invasiveness of serotypes and clones of Streptococcus pneumoniae among children in Finland. Infect. Immun. 73:431-435.
9. Austrian R. 1981. Some observations on the pneumococcus and on the current status of pneumococcal disease and its prevention. Rev. Infect. Dis. 3(Suppl):S1-S17.
10. McCormick AW, Whitney CG, Farley MM, Lynfield R, Harrison LH, Bennett NM, Schaffner W, Reingold A, Hadler J, Cieslak P, Samore MH, Lipsitch M. 2003. Geographic diversity and temporal trends of antimicrobial resistance in Streptococcus pneumoniae in the United States. Nat. Med. 9:424-430.
11. Hyams C, Trzcinski K, Camberlein E, Weinberger DM, Chimalapati S, Noursadeghi M, Lipsitch M, Brown JS. 2013. Streptococcus pneumoniae capsular serotype invasiveness correlates with the degree of factorHbinding and opsonization with C3b/iC3b. Infect. Immun. 81:354-363.
12. Hanage WP, Finkelstein JA, Huang SS, Pelton SI, Stevenson AE, Kleinman K, Hinrichsen VL, Fraser C. 2010. Evidence that pneumococcal serotype replacement in Massachusetts following conjugate vaccination is now complete. Epidemics 2:80-84.
13. Weinberger DM, Malley R, Lipsitch M. 2011. Serotype replacement in disease after pneumococcal vaccination. Lancet 378:1962-1973.
14. Whitney CG, Farley MM, Hadler J, Harrison LH, Bennett NM, Lynfield R, Reingold A, Cieslak PR, Pilishvili T, Jackson D, Facklam RR, Jorgensen JH, Schuchat A, Active Bacterial Core Surveillance of the Emerging Infections Program Network. 2003. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N. Engl. J. Med. 348:1737-1746.
15. Hicks LA, Harrison LH, Flannery B, Hadler JL, Schaffner W, Craig AS, Jackson D, Thomas A, Beall B, Lynfield R, Reingold A, Farley MM, Whitney CG. 2007. Incidence of pneumococcal disease due to nonpneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004. J. Infect. Dis. 196:1346-1354.
16. Huang SS, Platt R, Rifas-Shiman SL, Pelton SI, Goldmann D, Finkelstein JA. 2005. Post-PCV7 changes in colonizing pneumococcal serotypes in 16 Massachusetts communities, 2001 and 2004. Pediatrics 116:e408-e413.
17. Frazao N, Brito-Avo A, Simas C, Saldanha J, Mato R, Nunes S, Sousa NG, Carrico JA, Almeida JS, Santos-Sanches I, de Lencastre H. 2005. Effect of the seven-valent conjugate pneumococcal vaccine on carriage and drug resistance of Streptococcus pneumoniae in healthy children attending day-care centers in Lisbon. Pediatr. Infect. Dis. J. 24:243-252.
18. Singleton RJ, Hennessy TW, Bulkow LR, Hammitt LL, Zulz T, Hurlburt DA, Butler JC, Rudolph K, Parkinson A. 2007. Invasive pneumococcal disease caused by nonvaccine serotypes among Alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage. JAMA 297:1784-1792.
19. Gladstone RA, Jefferies JM, Faust SN, Clarke SC. 2012. Pneumococcal 13-valent conjugate vaccine for the prevention of invasive pneumococcal disease in children and adults. Exp. Rev. Vaccines 11:889-902.
20. Kamerling J. 2000. Pneumococcal polysaccharides: a chemical view, p 85-93. In Tomasz A (ed), Streptococcus pneumoniae: molecular biology & mechanisms of disease. Mary Ann Liebert, New York, NY.
21. Swiatlo E, Champlin FR, Holman SC, Wilson WW, Watt JM. 2002. Contribution of choline-binding proteins to cell surface properties of Streptococcus pneumoniae. Infect. Immun. 70:412-415.
22. Hogberg L, Geli P, Ringberg H, Melander E, Lipsitch M, Ekdahl K. 2007. Age- and serogroup-related differences in observed durations of nasopharyngeal carriage of penicillin-resistant pneumococci. J. Clin. Microbiol. 45:948-952.
23. Sleeman KL, Griffiths D, Shackley F, Diggle L, Gupta S, Maiden MC, Moxon ER, Crook DW, Peto TE. 2006. Capsular serotype-specific attack rates and duration of carriage of Streptococcus pneumoniae in a population of children. J. Infect. Dis. 194:682-688.
24. Lipsitch M, Abdullahi O, D'Amour A, Xie W, Weinberger DM, Tchetgen E, Scott JA. 2012. Estimating rates of carriage acquisition and clearance and competitive ability for pneumococcal serotypes in Kenya with a Markov transition model. Epidemiology 23:510-519.
25. Nelson AL, Roche AM, Gould JM, Chim K, Ratner AJ, Weiser JN. 2007. Capsule enhances pneumococcal colonization by limiting mucusmediated clearance. Infect. Immun. 75:83-90.
26. van Oss CJ. 1978. Phagocytosis as a surface phenomenon. Annu. Rev. Microbiol. 32:19-39.
27. Lu YJ, Gross J, Bogaert D, Finn A, Bagrade L, Zhang Q, Kolls JK, Srivastava A, Lundgren A, Forte S, Thompson CM, Harney KF, Anderson PW, Lipsitch M, Malley R. 2008. Interleukin-17A mediates acquired immunity to pneumococcal colonization. PLoS Pathog. 4:e1000159. doi:10.1371/journal.ppat.1000159.
28. Zhang Z, Clarke TB, Weiser JN. 2009. Cellular effectors mediating Th17-dependent clearance of pneumococcal colonization in mice. J. Clin. Investig. 119:1899-1909.
29. Weinberger DM, Trzcinski K, Lu YJ, Bogaert D, Brandes A, Galagan J, Anderson PW, Malley R, Lipsitch M. 2009. Pneumococcal capsular polysaccharide structure predicts serotype prevalence. PLoS Pathog. 5:e1000476. doi:10.1371/journal.ppat.1000476.
30. Wilson WW, Wade MM, Holman SC, Champlin FR. 2001. Status of methods for assessing bacterial cell surface charge properties based on zeta potential measurements. J. Microbiol. Methods 43:153-164.
31. Trzcinski K, Thompson CM, Lipsitch M. 2003. Construction of otherwise isogenic serotype 6B, 7F, 14, and 19F capsular variants of Streptococcus pneumoniae strain TIGR4. Appl. Environ. Microbiol. 69:7364-7370.
32. Adams MH, Roe AS. 1945. A partially defined medium for cultivation of pneumococcus. J. Bacteriol. 49:401-409.
33. Abdullahi O, Karani A, Tigoi CC, Mugo D, Kungu S, Wanjiru E, Jomo J, Musyimi R, Lipsitch M, Scott JA. 2012. The prevalence and risk factors for pneumococcal colonization of the nasopharynx among children in KilifiDistrict, Kenya. PLoS One 7:e30787. doi:10.1371/journal.pone.0030787.
34. Hanage WP, Huang SS, Lipsitch M, Bishop CJ, Godoy D, Pelton SI, Goldstein R, Huot H, Finkelstein JA. 2007. Diversity and antibiotic resistance among nonvaccine serotypes of Streptococcus pneumoniae carriage isolates in the post-heptavalent conjugate vaccine era. J. Infect. Dis. 195:347-352.
35. Bernheimer AW. 1953. Synthesis of type III pneumococcal polysaccharide by suspensions of resting cells. J. Exp. Med. 97:591-600.
36. Klinke A, Nussbaum C, Kubala L, Friedrichs K, Rudolph TK, Rudolph V, Paust HJ, Schroder C, Benten D, Lau D, Szocs K, Furtmuller PG, Heeringa P, Sydow K, Duchstein HJ, Ehmke H, Schumacher U, Meinertz T, Sperandio M, Baldus S. 2011. Myeloperoxidase attracts neutrophils by physical forces. Blood 117:1350-1358.
37. Weiser JN, Austrian R, Sreenivasan PK, Masure HR. 1994. Phase variation in pneumococcal opacity: relationship between colonial morphology and nasopharyngeal colonization. Infect. Immun. 62:2582-2589.
38. Arai J, Hotomi M, Hollingshead SK, Ueno Y, Briles DE, Yamanaka N. 2011. Streptococcus pneumoniae isolates from middle ear fluid and nasopharynx of children with acute otitis media exhibit phase variation. J. Clin. Microbiol. 49:1646-1649.
39. Mook-Kanamori BB, GeldhoffM, van der Poll T, van de Beek D. 2011. Pathogenesis and pathophysiology of pneumococcal meningitis. Clin. Microbiol. Rev. 24:557-591.
40. Brunworth JD, Garg R, Mahboubi H, Johnson B, Djalilian HR. 2012. Detecting nasopharyngeal reflux: a novel pH probe technique. Ann. Otol. Rhinol. Laryngol. 121:427-430.
41. Kozel TR, Reiss E, Cherniak R. 1980. Concomitant but not causal association between surface charge and inhibition of phagocytosis by cryptococcal polysaccharide. Infect. Immun. 29:295-300.